Tacrolimus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
Conditions:   GATA2;   Immunodeficiency Interventions:   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus;   Drug: Post-Transplant Cyclophosphamide;   Radiation: Total Body Irradiation;   Procedure: Hematopoietic Cell Transplant;   Drug: JSP191;   Drug: Cyclophosphamide;   Drug: Fludarabine Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials